Key statistics
As of last trade Hikma Pharmaceuticals PLC (HIK:LSE) traded at 1,956.00, -9.65% below its 52-week high of 2,165.00, set on Feb 22, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1,922.00 |
---|---|
High | 1,956.00 |
Low | 1,916.00 |
Bid | 1,956.00 |
Offer | 1,958.00 |
Previous close | 1,914.00 |
Average volume | 314.57k |
---|---|
Shares outstanding | 221.89m |
Free float | 154.92m |
P/E (TTM) | 19.84 |
Market cap | 4.25bn GBP |
EPS (TTM) | 0.965 GBP |
Annual div (ADY) | 61.41 GBX |
---|---|
Annual div yield (ADY) | 3.21% |
Div ex-date | Aug 15 2024 |
Div pay-date | Sep 20 2024 |
Data delayed at least 20 minutes, as of Sep 19 2024 15:15 BST.
More ▼
Investors Chronicle View
The last IC recommendation on Hikma Pharmaceuticals PLC shares was Buy at 1,975.00 on 08 Aug 2024Read the full article